(+/-)-ferruginol analogs and preparation method thereof, and applications of (+/-)-ferruginol analogs in preparation of antibacterial drugs
A technology of milopineol and its analogues, which is applied in the field of preparation of antibacterial drugs, and can solve problems such as raw materials and ligands are difficult to obtain, difficult to purify, and low in content
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0355] Embodiment 1: the preparation of (±)-melopineol analog shown in formula (6b), (6d), (7b), (10b), (10-1b), (12a)
[0356]
[0357] The structures of the (±)-mirospinol analogues shown in formulas (6b), (6d), (7b), (10b), (10-1b), (12a) are as follows:
[0358]
[0359] Preparation of (±)-meloconol analogs shown in formula (6b): Compound 1 (1g, 3.65mmol) was dissolved in anhydrous DCM (30mL), DMAP (222.9mg, 1.82mmol) was added, and B Acid anhydride (1.028mL, 10.95mmol), react at room temperature for 3 hours, add water (30mL), adjust pH to neutral with 2M HCl, extract with DCM (20mLx3), combine organic phases, wash with saturated brine (30mL), anhydrous sodium sulfate After drying, concentration, and silica gel column chromatography (PE:EA=20:1), compound 2 (white solid, 1.1 g, 95%) was obtained. 1 H NMR (400MHz, CDCl 3 )δ6.97(d, J=8.4Hz, 1H), 6.77(s, 1H), 6.68(d, J=8.4Hz, 1H), 4.55(dd, J=11.2, 4.0Hz, 1H), 3.77( s,3H),2.91(dd,J=16.4,6.0Hz,1H),2.84-2.75(m,1H),2.27(...
Embodiment 2
[0377] Embodiment 2: the preparation of (±)-melopineol analog shown in formula (15):
[0378]
[0379] Compound 1 (7.8g, 28.6mmol) was dissolved in anhydrous DCM (200mL), under nitrogen protection, when the system was cooled to 0°C, BBr was added dropwise 3 (7.54mL, 71mmol), react at 0°C for 0.5 hours. Add water (150mL), extract with DCM (50mLx3), combine the organic phases, wash with saturated brine (100mL), dry over anhydrous sodium sulfate, concentrate, and perform silica gel column chromatography (PE:EA=1000:1) to obtain compound 13 ( White solid, 5.64 g, 90.7%). 1 H NMR (400MHz, CDCl 3 )δ6.97(d,J=8.4Hz,1H),6.80(s,1H),6.68(d,J=8.4Hz,1H),5.62–5.58(m,1H),5.48(d,J=10.0 Hz,1H),3.78(s,3H),2.88–2.72(m,2H),2.52-2.46(m,1H),2.12(d,J=16.8Hz,1H),1.86-1.83(d,J= 11.7Hz, 1H), 1.69–1.61(m, 2H), 1.25(s, 3H), 1.04(s, 3H), 0.98(s, 3H).
[0380] Compound 13 (5 g, 19 mmol) was dissolved in anhydrous methanol (200 mL), protected under nitrogen, added 15% Pd\C (750 mg), replaced with hy...
Embodiment 3
[0382] Embodiment 3: the preparation of (±)-mirospinol analog shown in formula (19a), (19b), (19c), (19d), (19e):
[0383]
[0384] The structures of (±)-melopineol analogs shown in formulas (19a), (19b), (19c), (19d), (19e) are as follows:
[0385]
[0386] POCl 3 (16mL) was placed in a single-necked bottle under nitrogen protection. When the system was cooled to 0°C, DMF (9.56mL, 1.368mmol) was added dropwise, stirred at 0°C for 1 hour, and compound 14 (800mg, 3.1mmol) was added dropwise in CHCl 3 (7mL) solution, heated and refluxed for 12 hours, cooled and added water (100mL), extracted with DCM (40mLx3), combined organic phases, washed with saturated brine (60mL), dried over anhydrous sodium sulfate, concentrated, silica gel column chromatography (PE: EA=100:1), to obtain compound 16a (yellow solid, 672 mg, 75.8%). 1 H NMR (500MHz, CDCl 3 )δ10.37(s,1H),7.50(s,1H),6.85(s,1H),3.89(d,J=5.1Hz,3H),2.94-2.90(m,1H),2.83–2.76(m ,1H),2.26(d,J=12.5Hz,1H),1.91–1.87(m,1H),1....
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


